United States · FDA National Drug Code directory
Pradaxa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0597-0430_56b1a7c2-0afd-40c6-bda5-563e234a9f28
- Product NDC
- 0597-0430
- Form
- PELLET
- Composition / generic term
- dabigatran etexilate
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220316
- Source listing expiry
- 20261231
Source-listed ingredients
- DABIGATRAN ETEXILATE MESYLATE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BAG in 1 CARTON (0597-0430-18) / 60 PELLET in 1 BAG · 0597-0430-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →